Related Experiment Video
Updated: Feb 19, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.1K
Liposome-based immunity-inducing systems for cancer immunotherapy
1Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan.
Molecular Immunology
|November 13, 2017
Summary
Liposomes offer a versatile platform for cancer immunotherapy, enabling targeted antigen delivery to immune cells. Rational design of these liposome-based systems enhances antigen presentation and boosts anti-tumor immunity.
Area of Science:
- Immunology
- Biotechnology
- Materials Science
Background:
- Cancer immunotherapy is a promising next-generation cancer treatment.
- Efficient antigen delivery systems are crucial for effective cancer immunotherapy, requiring selective targeting, site-specific antigen release, and immune cell activation.
- Liposomes are multifunctional carriers with tunable properties suitable for antigen delivery.
Purpose of the Study:
- To review the rational design of liposome-based antigen delivery systems for cancer immunotherapy.
- To explore strategies for enhancing antigen delivery, cross-presentation, and immune activation using liposomes.
- To discuss the role of liposome modifications in overcoming tumor immunosuppression.
Main Methods:
- Surface modification of liposomes with pH-responsive or fusogenic materials for cytosolic antigen delivery.
- Targeting antigen-presenting cell surface receptors or utilizing selective endosomal antigen release for vacuolar pathway cross-presentation.
- Incorporation of adjuvant molecules (e.g., Toll-like receptor agonists, cationic lipids, polysaccharides) into liposomes.
- Combination of liposome systems with strategies to counteract tumor microenvironment immunosuppression.
Main Results:
- Liposome surface modifications enable distinct antigen delivery pathways (cytosolic or vacuolar) for cross-presentation.
- Adjuvant incorporation into liposomes enhances their immunogenicity.
- Combining liposome antigen delivery with immunosuppression cancellation strategies boosts anti-tumor immunity.
Conclusions:
- Liposome-based antigen delivery systems can be rationally designed for efficient cancer immunotherapy.
- Tailored liposome functionalization and adjuvant incorporation are key to improving immune responses.
- Further research into immune mechanisms and tumor immunosuppression will enable more effective liposome-based cancer immunotherapies.
Related Concept Videos
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:30Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
01:27Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K